Monday, November 24, 2025 12:41:32 PM
VTYX......................................https://stockcharts.com/sc3/ui/?s=VTYX&p=W&b=5&g=0&id=p86431144783
Recent VTYX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:20:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:17:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:15:13 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/04/2026 05:06:38 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/04/2026 04:57:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 02:22:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/23/2026 09:29:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:26:21 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 02/02/2026 09:05:24 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 01/22/2026 10:29:09 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/22/2026 09:18:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:16:21 PM
- Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm • PR Newswire (US) • 01/09/2026 01:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/07/2026 10:04:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 10:02:49 PM
- Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases • PR Newswire (US) • 01/07/2026 09:17:00 PM
